Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cardiac RadiothErapy for VEntricular Tachycardia II
Sponsor: Universitaire Ziekenhuizen KU Leuven
Summary
Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular tachycardia.
Official title: Cardiac RadiothErapy for VEntricular Tachycardia II - a Prospective Observational Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2025-01-01
Completion Date
2034-12
Last Updated
2025-01-07
Healthy Volunteers
No
Conditions
Interventions
stereotactic radiotherapy ablation
Single dose of 25 Gy up to 32.5 Gy on the myocardium in patients with therapy-refractory ventricular tachycardia
Locations (1)
UZ Leuven
Leuven, Belgium